Barclays PLC Insulet Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Insulet Corp stock. As of the latest transaction made, Barclays PLC holds 143,307 shares of PODD stock, worth $37.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

143,307

Previous 136,572 4.93%

Holding current value

$37.3 Million

Previous $27.6 Million 21.01%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$180.69 - $239.01 $1.22 Million - $1.61 Million	6,735 Added 4.93%	143,307 $33.4 Million
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $46.7 Million - $60 Million	-290,003 Reduced 67.98%	136,572 $27.6 Million
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $35.9 Million - $45.9 Million	219,350 Added 105.85%	426,575 $73.1 Million
Q4 2023 Feb 15, 2024	BUY	$127.77 - $221.42 $10.5 Million - $18.2 Million	82,297 Added 65.88%	207,225 $45 Million
Q3 2023 Nov 07, 2023	SELL	$154.67 - $290.89 $2.32 Million - $4.36 Million	-14,981 Reduced 10.71%	124,928 $19.9 Million
Q2 2023 Aug 03, 2023	BUY	$272.48 - $330.23 $18.5 Million - $22.4 Million	67,902 Added 94.3%	139,909 $40.3 Million
Q1 2023 May 04, 2023	BUY	$276.36 - $326.03 $6.46 Million - $7.63 Million	23,391 Added 48.11%	72,007 $23 Million
Q4 2022 Feb 13, 2023	BUY	$212.22 - $313.46 $2.32 Million - $3.43 Million	10,934 Added 29.02%	48,616 $14.3 Million
Q3 2022 Nov 03, 2022	BUY	$224.6 - $281.45 $463,349 - $580,631	2,063 Added 5.79%	37,682 $8.64 Million
Q2 2022 Aug 12, 2022	BUY	$186.4 - $279.02 $638,420 - $955,643	3,425 Added 10.64%	35,619 $7.76 Million
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $4.03 Million - $5.7 Million	-20,663 Reduced 39.09%	32,194 $8.58 Million
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $282,639 - $352,347	-1,107 Reduced 2.05%	52,857 $14.1 Million
Q3 2021 Nov 09, 2021	BUY	$260.36 - $307.27 $1.4 Million - $1.65 Million	5,369 Added 11.05%	53,964 $15.3 Million
Q2 2021 Aug 13, 2021	BUY	$225.52 - $304.06 $2.58 Million - $3.47 Million	11,426 Added 30.74%	48,595 $13.3 Million
Q1 2021 May 13, 2021	BUY	$235.95 - $293.05 $1.33 Million - $1.66 Million	5,651 Added 17.93%	37,169 $9.7 Million
Q4 2020 Feb 11, 2021	SELL	$215.97 - $265.89 $347,495 - $427,817	-1,609 Reduced 4.86%	31,518 $8.06 Million
Q3 2020 Nov 12, 2020	BUY	$192.55 - $236.59 $1.21 Million - $1.49 Million	6,290 Added 23.44%	33,127 $7.84 Million
Q2 2020 Aug 12, 2020	SELL	$159.17 - $224.73 $668,036 - $943,191	-4,197 Reduced 13.52%	26,837 $5.21 Million
Q1 2020 May 13, 2020	SELL	$130.01 - $216.44 $4.08 Million - $6.79 Million	-31,367 Reduced 50.27%	31,034 $5.14 Million
Q4 2019 Feb 10, 2020	BUY	$144.81 - $186.0 $7.14 Million - $9.17 Million	49,293 Added 376.05%	62,401 $10.7 Million
Q3 2019 Nov 14, 2019	SELL	$117.35 - $167.95 $922,488 - $1.32 Million	-7,861 Reduced 37.49%	13,108 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$82.13 - $120.73 $726,850 - $1.07 Million	8,850 Added 73.03%	20,969 $2.5 Million
Q1 2019 May 15, 2019	BUY	$72.44 - $101.87 $403,708 - $567,721	5,573 Added 85.14%	12,119 $1.15 Million
Q4 2018 Feb 14, 2019	SELL	$73.27 - $105.19 $286,998 - $412,029	-3,917 Reduced 37.44%	6,546 $519,000
Q3 2018 Nov 14, 2018	SELL	$81.43 - $108.13 $9.19 Million - $12.2 Million	-112,871 Reduced 91.52%	10,463 $1.11 Million
Q2 2018 Aug 14, 2018	BUY	$83.27 - $101.93 $7.69 Million - $9.42 Million	92,373 Added 298.35%	123,334 $10.6 Million
Q1 2018 May 15, 2018	BUY	$68.49 - $87.2 $1.45 Million - $1.84 Million	21,127 Added 214.84%	30,961 $2.68 Million
Q4 2017 Feb 14, 2018	BUY	$55.67 - $71.8 $472,471 - $609,366	8,487 Added 630.07%	9,834 $678,000
Q3 2017 Nov 14, 2017	BUY	$49.68 - $59.46 $66,918 - $80,092	1,347	1,347 $74,000

Others Institutions Holding PODD

# of Institutions

685

Shares Held

62.7M

Call Options Held

640K

Put Options Held

881K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account